NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: SAFETY AND TOLERABILITY

被引:0
|
作者
Glaspole, I [1 ,2 ]
Lancaster, L. [3 ]
Hernandez, P. [4 ]
Inoue, Y. [5 ]
Wachtlin, D. [6 ]
Loaiza, L. [6 ]
Conoscenti, C. [7 ]
Quaresma, M. [6 ,8 ,9 ]
Stowasser, S. [6 ]
Richeldi, L. [10 ]
机构
[1] Alfred Hlth, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia
[2] Monash Univ, Dept Med, Melbourne, Vic, Australia
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] QEII Hlth Sci Ctr, Halifax, NS, Canada
[5] Natl Hosp Org Kinki Chuo Chest Med Ctr, Clin Res Ctr, Osaka, Japan
[6] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[7] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[8] Heidelberg Univ, Thoraxklin, Ctr Interstitial & Rare Lung Dis Pneumol & Resp C, Heidelberg, Germany
[9] German Ctr Lung Res, Giessen, Germany
[10] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli, Rome, Italy
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
TO 025
引用
收藏
页码:34 / 34
页数:1
相关论文
共 50 条
  • [1] Tolerability and safety of nintedanib in elderly patients with idiopathic pulmonary fibrosis
    Uchida, Yoshinori
    Ikeda, Satoshi
    Sekine, Akimasa
    Katano, Takuma
    Tabata, Erina
    Oda, Tsuneyuki
    Okuda, Ryo
    Kitamura, Hideya
    Baba, Tomohisa
    Komatsu, Shigeru
    Ogura, Takashi
    [J]. RESPIRATORY INVESTIGATION, 2021, 59 (01) : 99 - 105
  • [2] Safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis in the USA
    Noth, Imre
    Oelberg, David
    Kaul, Manika
    Conoscenti, Craig S.
    Raghu, Ganesh
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (01)
  • [3] The safety and tolerability of nintedanib in the treatment of idiopathic pulmonary fibrosis
    Cottin, Vincent
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (07) : 857 - 865
  • [4] Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
    Tamera Corte
    Francesco Bonella
    Bruno Crestani
    Maurits G. Demedts
    Luca Richeldi
    Carl Coeck
    Katy Pelling
    Manuel Quaresma
    Joseph A. Lasky
    [J]. Respiratory Research, 16
  • [5] Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis
    Corte, Tamera
    Bonella, Francesco
    Crestani, Bruno
    Demedts, Maurits G.
    Richeldi, Luca
    Coeck, Carl
    Pelling, Katy
    Quaresma, Manuel
    Lasky, Joseph A.
    [J]. RESPIRATORY RESEARCH, 2015, 16
  • [6] Safety, Tolerability and Efficacy of Nintedanib Switched from Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
    Ikeda, S.
    Sekine, A.
    Baba, T.
    Katano, T.
    Matama, G.
    Aiko, N.
    Isomoto, K.
    Otoshi, R.
    Tabata, E.
    Shintani, R.
    Sadoyama, S.
    Yamakawa, H.
    Niwa, T.
    Nakagawa, H.
    Oda, T.
    Okuda, R.
    Kitamura, H.
    Komatsu, S.
    Hagiwara, E.
    Ogura, T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [7] Tolerability of nintedanib-related diarrhea in patients with idiopathic pulmonary fibrosis
    Hirasawa, Yasutaka
    Abe, Mitsuhiro
    Terada, Jiro
    Sakayori, Masashi
    Suzuki, Kenichi
    Yoshioka, Keiichiro
    Kawasaki, Takeshi
    Tsushima, Kenji
    Tatsumi, Koichiro
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2020, 62
  • [8] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Luca Richeldi
    Martin Kolb
    Stéphane Jouneau
    Wim A. Wuyts
    Birgit Schinzel
    Susanne Stowasser
    Manuel Quaresma
    Ganesh Raghu
    [J]. BMC Pulmonary Medicine, 20
  • [9] Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
    Richeldi, Luca
    Kolb, Martin
    Jouneau, Stephane
    Wuyts, Wim A.
    Schinzel, Birgit
    Stowasser, Susanne
    Quaresma, Manuel
    Raghu, Ganesh
    [J]. BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [10] SAFETY OF COMBINED PIRFENIDONE AND NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Flaherty, K. R.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    [J]. THORAX, 2017, 72 : A253 - A254